These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physicochemical properties of calcium polycarbophil, a water-absorbing polymer. Yamada T; Kitayama M; Yamazaki M; Nagata O; Tamaj I; Tsuji A J Pharm Pharmacol; 1996 Jul; 48(7):665-8. PubMed ID: 8866325 [TBL] [Abstract][Full Text] [Related]
3. Impairment of ciprofloxacin absorption by calcium polycarbophil. Kato R; Ueno K; Imano H; Kawai M; Kuwahara S; Tsuchishita Y; Yonezawa E; Tanaka K J Clin Pharmacol; 2002 Jul; 42(7):806-11. PubMed ID: 12092748 [TBL] [Abstract][Full Text] [Related]
4. [Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)]. Iwanaga Y Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):185-90. PubMed ID: 11915521 [TBL] [Abstract][Full Text] [Related]
5. Absorbability of calcium from a new calcium supplement prepared from bovine marrow-free bone in rats. Ohtani M; Tsugawa N; Kamao M; Okano T J Nutr Sci Vitaminol (Tokyo); 1998 Dec; 44(6):887-95. PubMed ID: 10197319 [TBL] [Abstract][Full Text] [Related]
6. Canine gastric emptying of polycarbophil: an indigestible, particulate substance. Russell J; Bass P Gastroenterology; 1985 Aug; 89(2):307-12. PubMed ID: 4007422 [TBL] [Abstract][Full Text] [Related]
7. The enhancement of pipemidic acid permeation into the pig urinary bladder wall. Kerec M; Svigelj V; Bogataj M; Mrhar A Int J Pharm; 2002 Jun; 240(1-2):33-6. PubMed ID: 12062499 [TBL] [Abstract][Full Text] [Related]
8. Mucoadhesion on pig vesical mucosa: influence of polycarbophil/calcium interactions. Kerec M; Bogataj M; Mugerle B; Gasperlin M; Mrhar A Int J Pharm; 2002 Jul; 241(1):135-43. PubMed ID: 12086729 [TBL] [Abstract][Full Text] [Related]
10. Adsorption of inorganic and organic ions to polycarbophil as a means of sustained-release dosage formulation. See NA; Russell J; Connors KA; Bass P Pharm Res; 1987 Jun; 4(3):244-7. PubMed ID: 3509289 [TBL] [Abstract][Full Text] [Related]
11. Safety of repeated topical ocular administration of a polycarbophil-based formulation in several models of ocular surgery in rabbits. Krenzer KL; Zhang JZ; Coffey MJ; Richardson ME J Cataract Refract Surg; 2012 Apr; 38(4):696-704. PubMed ID: 22440439 [TBL] [Abstract][Full Text] [Related]
12. Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat. Lehr CM; Bouwstra JA; Kok W; De Boer AG; Tukker JJ; Verhoef JC; Breimer DD; Junginger HE J Pharm Pharmacol; 1992 May; 44(5):402-7. PubMed ID: 1359054 [TBL] [Abstract][Full Text] [Related]
13. A simple test of intestinal absorption of calcium in rats. Rubinger D; Krause I; Alcoby-Gibbs M; Popovtzer MM Nephron; 1991; 57(2):206-9. PubMed ID: 2020349 [TBL] [Abstract][Full Text] [Related]
14. Effect of polycarbophil on the absorption of nutrients. Yamada T; Nagata O; Tamai I; Tsuji A Biol Pharm Bull; 1996 May; 19(5):771-3. PubMed ID: 8741594 [TBL] [Abstract][Full Text] [Related]
15. Lack of inhibition of adhesion of an enteropathogenic Escherichia coli by polycarbophil. Mack DR; Blain-Nelson PL; Mauger JW J Biomed Mater Res; 1993 Dec; 27(12):1579-83. PubMed ID: 8113246 [TBL] [Abstract][Full Text] [Related]
16. Intestinal absorption of calcium from calcium ascorbate in rats. Tsugawa N; Yamabe T; Takeuchi A; Kamao M; Nakagawa K; Nishijima K; Okano T J Bone Miner Metab; 1999; 17(1):30-6. PubMed ID: 10084399 [TBL] [Abstract][Full Text] [Related]
17. Design and in vivo evaluation of a patch system based on thiolated polymers. Hoyer H; Greindl M; Bernkop-Schnürch A J Pharm Sci; 2009 Feb; 98(2):620-7. PubMed ID: 18661531 [TBL] [Abstract][Full Text] [Related]
18. Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. Longer MA; Ch'ng HS; Robinson JR J Pharm Sci; 1985 Apr; 74(4):406-11. PubMed ID: 3999000 [TBL] [Abstract][Full Text] [Related]
19. Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarbophil. Chiba T; Sato K; Toya Y; Endo K; Abiko Y; Kasugai S; Saito S; Oana S; Kudara N; Endo M; Suzuki K Hepatogastroenterology; 2011; 58(110-111):1527-30. PubMed ID: 21940313 [TBL] [Abstract][Full Text] [Related]
20. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil. Chiba T; Kudara N; Sato M; Chishima R; Abiko Y; Inomata M; Orii S; Suzuki K Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]